See also this year's filing and all EDGAR filings for this company.
PDF Report 0000875622_2015_Biospecifics_Technologies_CORP.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000875622, Biospecifics Technologies CORP
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 25,148,810 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 295,030 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 5,582,984 |
| 4 | LiabilitiesCurrent | 671,212 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,754,437 |
| 9 | ResearchAndDevelopmentExpense | 1,184,790 |
| 10 | remainder_Expenses | 2,438,995 |
| 11 | remainder_Revenues | 14,090,382 |
| 12 | remainder_NetIncome | 31,393 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 31,026,824 |
| 1 | Liabilities | 671,212 |
| 2 | Expenses | 9,378,222 |
| 3 | Revenues | 14,090,382 |
| 4 | StockholdersEquity | 30,355,612 |
| 5 | NetIncome | 4,743,553 |
| 6 | ComprehensiveNetIncome | 4,743,553 |
| 7 | BaseVar | 27,599,016 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.47 |
| 9 | EconomicCapitalRatio | 4.76 |